PROCESSED CHEESE PRODUCTS AND PROCESS FOR PRODUCING PROCESSED CHHESE

摘要

In order to obtain a sufficient hypotensive effect in a small intake dose, it is intended to provide processed cheese products having improved hypotensive effect compared with ordinary cheese products. More specifically speaking, a processed cheese product having an angiotensin converting enzyme (ACE) inhibitory activity of 350 U/g or more is produced by using a natural cheese having an ACE inhibitory activity of 420 U/g or more such as cheddar cheese made in New Zealand or Emmental cheese made in Switzerland. It is preferable that a low-salt or salt-free natural cheese is used as the starting material or a potassium salt is used as a molten salt to thereby regulate the sodium content to 990 mg or less per 100 g of the processed cheese.